drugset / Trial / NCT06762964

CAMEO-FONTAN -Dapagliflozin in the Failing Fontan Circulation

NCT06762964

Phase 2 Recruiting 27 enrolled Mayo Clinic
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this research is to determine whether treatment with the study drug dapagliflozin for 3 months affects peripheral venous pressure at rest and during exercise in adults with failing Fontan circulation.

Timeline

Start
2025-05-16
Primary completion
2027-02
Completion
2027-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Dapagliflozin Small molecule 10 mg